This company listing is no longer active
THAC Stock Overview
Thrive Acquisition Corporation does not have significant operations.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Thrive Acquisition Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.36 |
| 52 Week High | US$12.97 |
| 52 Week Low | US$9.89 |
| Beta | 0 |
| 1 Month Change | 0.44% |
| 3 Month Change | 1.42% |
| 1 Year Change | 4.18% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 4.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| THAC | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | -0.05% | -3.1% | -1.7% |
| 1Y | 4.2% | 25.4% | 22.9% |
Return vs Industry: THAC exceeded the US Capital Markets industry which returned -9.6% over the past year.
Return vs Market: THAC exceeded the US Market which returned -9.7% over the past year.
Price Volatility
| THAC volatility | |
|---|---|
| THAC Average Weekly Movement | 0.4% |
| Capital Markets Industry Average Movement | 3.3% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: THAC has not had significant price volatility in the past 3 months.
Volatility Over Time: THAC's weekly volatility (0%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Charles Jobson | www.thriveacquisitions.com |
Thrive Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in consumer health and wellness industry. The company was incorporated in 2021 and is based in Newton, Massachusetts.
Thrive Acquisition Corporation Fundamentals Summary
| THAC fundamental statistics | |
|---|---|
| Market cap | US$223.28m |
| Earnings (TTM) | US$11.42m |
| Revenue (TTM) | n/a |
19.6x
P/E Ratio0.0x
P/S RatioIs THAC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| THAC income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | -US$11.42m |
| Earnings | US$11.42m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.53 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did THAC perform over the long term?
See historical performance and comparison